Don't show this message again
21 U.S. Code § 379j-41. Definitions
For purposes of this subpart:(1) The term “abbreviated new drug application”—
(A)
means an application submitted under section 355(j) of this title, an abbreviated application submitted under section 357 of this title (as in effect on the day before November 21, 1997), or an abbreviated new drug application submitted pursuant to regulations in effect prior to the implementation of the Drug Price Competition and Patent Term Restoration Act of 1984; and
(B) does not include an application—
(i)
for a positron emission tomography drug; or
(ii)
submitted by a State or Federal governmental entity for a drug that is not distributed commercially.
(2) The term “active pharmaceutical ingredient” means—
(A) a substance, or a mixture when the substance is unstable or cannot be transported on its own, intended—
(i)
to be used as a component of a drug; and
(ii)
to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease, or to affect the structure or any function of the human body; or
(B)
a substance intended for final crystallization, purification, or salt formation, or any combination of those activities, to become a substance or mixture described in subparagraph (A).
(3)
The term “adjustment factor” means a factor applicable to a fiscal year that is the Consumer Price Index for all urban consumers (all items; United States city average) for October of the preceding fiscal year divided by such Index for October 2011.
(4) The term “affiliate” means a business entity that has a relationship with a second business entity if, directly or indirectly—
(A)
one business entity controls, or has the power to control, the other business entity; or
(B)
a third party controls, or has power to control, both of the business entities.